Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Apr 26;106(5):dju081.
doi: 10.1093/jnci/dju081.

Response

Affiliations
Comment

Response

Ian E Haines et al. J Natl Cancer Inst. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Ratios of treatments for patients in the control arm (black) to the same treatment for patients in the screening arm (shaded) in the GOTEBORG trial. ADT = primary endocrine treatment; PROST = primary radical prostatectomy; RAD = primary radiation; SURV = surveillance at last follow-up. Data from Table 3 of Hugosson et al. (2).

Comment on

References

    1. Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366(11):981–990. - PMC - PubMed
    1. Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol. 2010;11(8):725–732. - PMC - PubMed
    1. Chou R, Croswell JM, Dana T. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(11):762–771. - PubMed
    1. Haines IE, Miklos GLG. Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. J Natl Cancer Inst. 2013; 105(20):1534–1539. - PubMed
    1. Haines IE, Miklos GLG. Re: prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection. Response to Walsh. JNCI J Natl Cancer Inst (2014). 106 (2) djt433 10.1093/jnci/djt433. - PubMed